The modern human diet is characterized by an abundance of processed foods, making excessive sodium intake a pervasive global health challenge. While the medical community has long understood that a high-salt diet significantly increases the risk of hypertension, cardiovascular disease, and stroke, growing scientific evidence suggests that the consequences of consuming too much salt extend far beyond blood pressure. Recent studies indicate that excessive dietary sodium may also actively interfere with cognitive functions, including memory, complex thinking, and emotional well-being. Because high-salt consumption remains deeply entrenched in daily eating habits worldwide, identifying therapeutic interventions or dietary components capable of mitigating these neurological and vascular risks has become an urgent priority for public health researchers.
In a recent development addressing this concern, researchers in Japan have identified a promising therapeutic candidate in LPC70, a specialized compound derived from soybeans. Building upon previous findings which demonstrated that this ingredient could successfully reduce both high blood pressure and cognitive deficits in mice subjected to a high-salt diet, a team of scientists has now unraveled the specific physiological mechanisms at play. Their latest investigation reveals that LPC70 exerts its protective effects by finely modulating crucial chemical signaling pathways located in both the kidneys and the brain, offering a clearer picture of how nutrition can directly influence complex organ interactions.
How a Soy Compound May Counter the Effects of Excess Salt
At the core of the new research are prostaglandins, a group of powerful signaling molecules synthesized within the body from a fatty acid known as arachidonic acid. Functioning in a manner similar to local hormones, these substances play indispensable roles in regulating a wide array of vital physiological processes across various organ systems. Within the cardiovascular network, prostaglandins are instrumental in managing blood pressure by delicately balancing the constriction and dilation of blood vessels.
However, their functions within the central nervous system are significantly more complex. Depending on the specific cellular receptors they bind to and activate, prostaglandins can trigger biochemical signals that either protect vulnerable nerve cells or instigate detrimental inflammatory processes, which in turn can disrupt memory formation, cognitive processing, and emotional regulation.
The compound under investigation, LPC70, is a specialized form of soy lysolecithin characterized by a high concentration of lysophosphatidylcholine, accounting for more than 70 percent of its total phospholipid content. Although earlier laboratory experiments confirmed that LPC70 could alleviate salt-induced hypertension and cognitive impairments in animal models, the exact biological mechanisms—particularly its influence on prostaglandin signaling pathways—remained poorly understood.
To bridge this knowledge gap, a collaborative research team spearheaded by Professor Akihiro Mouri and Dr. Hisayoshi Kubota, in close partnership with Dr. Kazuhiro Kagotani, set out to examine the precise molecular impacts of LPC70 administration on mice maintained on a high-salt diet.
Dr. Kubota, serving as the study’s first author, was instrumental in conducting and overseeing the complex experiments. His work encompassed measuring arterial blood pressure, observing subtle behavioral shifts, and analyzing the underlying molecular activity associated with prostaglandin pathways. His detailed evaluations helped clarify how LPC70 successfully generates protective responses across the distinct organ systems responsible for salt-related cardiovascular and cognitive dysfunction.
The leadership behind the study is anchored in academic and industrial collaboration. Prof. Mouri and Dr. Kubota conduct their research within the Department of Regulatory Science for Evaluation and Development of Pharmaceuticals and Devices at the Fujita Health University Graduate School of Medical Science, alongside their affiliations with the International Center for Brain Science at Fujita Health University in Japan. Dr. Kagotani brings an industry perspective to the project, holding affiliations with Tsuji Oil Mills Co., Ltd. in Japan and the Tsuji Health and Beauty Science Laboratory at Mie University.
The findings resulting from their collaborative efforts were officially released online on May 14, 2026, and subsequently published in Volume 197 of the academic journal Neurochemistry International on July 1, 2026.
Refining the scope of the project, Prof. Mouri noted the initial impetus behind the investigation. "We wanted to understand the role of LPC70 in coordinating changes in PG signaling across organ systems," he remarked. He further explained that the study originated from an ongoing collaborative research initiative with Tsuji Oil Mills Co., Ltd., an enterprise specializing in the development of naturally derived food ingredients.
Soy Compound Improves Blood Pressure and Memory in Mice
As anticipated by the research team, laboratory mice subjected to a high-salt diet quickly developed elevated blood pressure, confirming the immediate cardiovascular toll of excess sodium. However, the negative ramifications of the high-salt regimen extended well beyond systemic vascular health.
Behavioral evaluations revealed that the animals also experienced a noticeable decline in social interaction and developed significant difficulties in recognizing familiar objects they had previously encountered, pointing to clear impairments in recognition memory. Interestingly, general locomotor activity and baseline anxiety-like behaviors remained largely unchanged among the subjects. This specific pattern indicates that excessive dietary salt selectively disrupts higher-order cognitive and social processing rather than inducing generalized neurological or physical impairment.
When the researchers introduced LPC70 as a dietary supplement to the salt-loaded mice, a notable reversal of these detrimental effects was observed. The animals exhibited measurable improvements in blood pressure regulation alongside enhanced performance in standardized behavioral tests measuring social interaction and object recognition memory. These encouraging physiological and cognitive recoveries prompted the team to delve deeper into the molecular changes occurring within the animals’ target tissues, specifically focusing on the kidneys and the brain.
Different Protective Effects in the Kidneys and Brain
Upon analyzing the renal tissue, the scientists discovered that a high-salt diet significantly upregulated the expression of two key molecular components involved in prostaglandin signaling: cyclooxygenase-2, commonly known as COX-2, and the PGE2 receptor subtype known as EP3. Both of these factors are strongly implicated in driving the development of hypertension linked to high sodium intake.
The administration of LPC70 successfully suppressed these salt-related elevations, indicating that the soy-derived compound helps correct aberrant signaling pathways in the kidneys that would otherwise compromise normal blood pressure control.
Conversely, the research team observed a distinctly different response within the prefrontal cortex, a critical region of the brain responsible for executive function, cognitive flexibility, memory retention, and social behavior. Consumption of excess salt led to a reduction in the expression of the PGD2 receptor DP1, a protein that normally facilitates protective and anti-inflammatory signaling pathways within neural tissue.
When treated with LPC70, the mice experienced a restoration of DP1 receptor expression, while levels of DP2—another receptor associated with potentially neurotoxic effects—remained unaltered.
This nuanced distinction is vital, as it demonstrates that LPC70 does not function as a blunt instrument that merely amplifies or suppresses all prostaglandin activity indiscriminately. Instead, the compound selectively reinforces signaling pathways that protect cerebral tissue from damage, providing a plausible molecular explanation for the observed recovery of memory and social functioning in the treated animals.
A Surprising Change in Chemical Signaling
In addition to mapping receptor expression, the investigative team uncovered an unexpected biochemical shift involving arachidonic acid, the foundational fatty acid utilized by mammalian bodies to synthesize prostaglandins.
Mice maintained on a high-salt diet characteristically displayed lower circulating levels of available arachidonic acid. Paradoxically, when these same mice were supplemented with LPC70, tissue levels of downstream prostaglandins derived from this fatty acid—specifically PGE2 and PGD2—actually increased.
This seemingly contradictory biochemical outcome suggests that LPC70 may optimize metabolic efficiency, enabling the body to utilize available pools of arachidonic acid more effectively for prostaglandin synthesis even under the physiological stress of a high-salt environment.
Taken together, the collective findings paint a picture of a coordinated yet highly selective therapeutic response. In the renal system, LPC70 appears to downregulate signaling cascades linked to hypertension, while in the central nervous system, it reactivates pathways dedicated to inflammation defense and neural protection. Consequently, the compound’s protective efficacy is determined by both the anatomical site and the specific prostaglandin receptor profiles involved.
Could Soy-Based Ingredients Help Protect Against Excess Salt?
The implications of these findings raise the possibility that LPC70 could eventually be developed into a functional food ingredient designed to mitigate some of the widespread health risks associated with excessive sodium consumption. Its demonstrated capacity to simultaneously improve vascular and cognitive parameters in experimental models suggests a dual-action benefit for cardiovascular and neurological health, particularly for individuals who find it difficult to maintain a low-sodium diet.
Nevertheless, the research team emphasizes that these promising results are derived strictly from preclinical animal experiments. Comprehensive human clinical trials are essential to determine whether these physiological benefits translate effectively to people.
Concluding the study’s implications, Prof. Mouri noted the broader horizons opened by the research. "Our study elucidates LPC70’s role in PG signaling, laying the groundwork for future clinical research and dietary interventions aimed at reducing hypertension-related cognitive decline and promoting healthy aging globally," he stated.
The investigation provides a clearer scientific foundation regarding how a naturally derived soy compound can interact with the body’s internal signaling networks to buffer the consequences of excessive salt intake, pointing toward novel nutritional strategies for preserving long-term health.
The study was made possible through financial support provided by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science under reference numbers 20K07931, 22K07606, 22K11891, and 23H02843. Additional support was secured through the Fujita Mind-Brain Research & Innovation Center for Drug Generation via Japan’s Peak Research Universities Program under grant JPJS00420240019, alongside the Japan Science and Technology Agency FOREST Program under grant JPMJFR215H. Furthermore, operational funding and material support were supplied by Tsuji Oil Mills Co., Ltd., along with grants and facilities provided by the Education and Research Facility of Animal Models for Human Diseases at Fujita Health University, the Smoking Research Foundation, and the Takeda Science Foundation.